Pacira BioSciences, Inc.

Ownership Transactions Reported by 27 Insiders

Symbol
PCRX on Nasdaq
Location
5401 West Kennedy Boulevard, Suite 890, Tampa, FL

Insiders trading volume in the past year

Pacira BioSciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David M. Stack CEO and Chairman, Director $9.69M Jun 14, 2023
Kristen Williams Chief Administrative Officer $2.92M -$211K -6.75% Jun 12, 2024
Daryl Gaugler Chief Operating Officer $2.28M -$44.7K -1.93% Dec 13, 2024
Jonathan Slonin Chief Medical Officer $1.89M -$242K -11.4% Aug 1, 2024
Roy Winston Chief Medical Officer $1.68M Aug 2, 2023
Charles A. Reinhart III Chief Financial Officer $1.47M Jun 12, 2024
Charles Anthony Laranjeira Chief Technical Officer $1.34M Jun 14, 2022
Frank D. Lee Chief Executive Officer, Director $1.3M +$100K +8.3% Aug 12, 2024
Dennis McLoughlin Chief Customer Officer $1.22M Jun 6, 2023
Lauren Riker Senior Vice President, Finance $1.09M -$114K -9.44% Jun 12, 2024
Ronald J. Ellis Jr. Chief Strategy Officer $989K Jun 6, 2023
Shawn Cross Chief Financial Officer $965K Nov 1, 2024
Donald C. Manning Chief Medical Officer $945K Jun 9, 2021
Max Reinhardt President, Rest of World $935K Jun 6, 2023
Mark A. Kronenfeld Director $769K Jun 12, 2024
Gary Pace Director $677K -$3.66M -84.4% Mar 6, 2024
John P. Longenecker Phd Director $602K Mar 3, 2022
Yvonne Greenstreet Director $424K Jun 8, 2022
Anthony Molloy Chief Lgl & Compliance Officer $412K Jun 5, 2023
Paul J. Hastings Director $361K -$25K -6.47% Jun 12, 2024
Christopher Christie Director $298K Jun 12, 2024
Laura Brege Director $225K +$12.8K +6.04% Aug 16, 2024
Mark Froimson Director $168K +$16.2K +10.7% Aug 12, 2024
Abraham Ceesay Director $148K Jun 12, 2024
Alethia Young Director $148K Jun 12, 2024
Marcelo Bigal Director $134K +$102K +311% Aug 16, 2024
Michael J. Yang Director $93.3K +$25.8K +38.2% Aug 14, 2024

Recent Insider Transactions by Companies or Individuals for Pacira BioSciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.